Nucleic Acid Isolation & Purification Segmentation
Product (Kits & Reagents, Instruments, Automated Systems)
Based on product, the kits & reagents segment is expected to garner the highest share of 62.7% in the nucleic acid isolation and purification market by the end of 2037. The dominance of the segment is attributed to the growing demand for affordable solutions in healthcare facilities. Moreover, the products are the ideal choice for various applications such as gene sequencing, diagnostics, and molecular biology research. In this regard, WHO reports 355 million annual viral hepatitis tests, mostly using RNA extraction kits, an augmentation of innovation in extraction kits, further accelerating the segment’s dominance.
Application (Diagnostics, Drug Discovery, Genomics, Agriculture)
Based on the application, the diagnostics segment is projected to account for a lucrative share of 48.9% in the nucleic acid isolation and purification market during the forecast period. The growth in the segment is subject to increased applications of DNA and RNA isolation for the identification of pathogens in routine sample processing. Besides, the Medicare expenditure for companion diagnostics associated with nucleic acid purification increased by 25%, i.e., USD 900 million in 2023, further contributing to the dominance of the segment. Additionally, the occurrence of COVID-19 remarkably increased the demand for innovative diagnostic tools.
Our in-depth analysis of the nucleic acid isolation and purification market includes the following segments:
|
Product |
|
|
Application |
|
|
Method |
|
|
End Use |
|
